Replimune Group Statistics

Total Valuation

Replimune Group has a market cap or net worth of $212.21 million. The enterprise value is $26.03 million.

Market Cap	212.21M
Enterprise Value	26.03M

Important Dates

The next estimated earnings date is Thursday, May 21, 2026, before market open.

Earnings Date	May 21, 2026
Ex-Dividend Date	n/a

Share Statistics

Replimune Group has 82.57 million shares outstanding. The number of shares has increased by 22.99% in one year.

Current Share Class	82.57M
Shares Outstanding	82.57M
Shares Change (YoY)	+22.99%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	1.80%
Owned by Institutions (%)	76.62%
Float	62.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.01
P/TBV Ratio	1.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.36.

Current Ratio	5.60
Quick Ratio	5.43
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-40.70

Financial Efficiency

Return on equity (ROE) is -90.88% and return on invested capital (ROIC) is -47.94%.

Return on Equity (ROE)	-90.88%
Return on Assets (ROA)	-43.24%
Return on Invested Capital (ROIC)	-47.94%
Return on Capital Employed (ROCE)	-114.36%
Weighted Average Cost of Capital (WACC)	8.32%
Revenue Per Employee	n/a
Profits Per Employee	-$657,313
Employee Count	479
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-418,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.60% in the last 52 weeks. The beta is 0.74, so Replimune Group's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-71.60%
50-Day Moving Average	6.22
200-Day Moving Average	7.08
Relative Strength Index (RSI)	34.23
Average Volume (20 Days)	10,583,899

Short Selling Information

The latest short interest is 18.43 million, so 22.31% of the outstanding shares have been sold short.

Short Interest	18.43M
Short Previous Month	16.34M
Short % of Shares Out	22.31%
Short % of Float	29.29%
Short Ratio (days to cover)	2.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-324.22M
Pretax Income	-315.27M
Net Income	-314.85M
EBITDA	-318.88M
EBIT	-324.22M
Earnings Per Share (EPS)	-$3.44

Full Income Statement

Balance Sheet

The company has $269.14 million in cash and $76.35 million in debt, giving a net cash position of $192.79 million or $2.33 per share.

Cash & Cash Equivalents	269.14M
Total Debt	76.35M
Net Cash	192.79M
Net Cash Per Share	$2.33
Equity (Book Value)	210.54M
Book Value Per Share	2.64
Working Capital	230.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$277.91 million and capital expenditures -$5.35 million, giving a free cash flow of -$283.27 million.

Operating Cash Flow	-277.91M
Capital Expenditures	-5.35M
Depreciation & Amortization	5.34M
Net Borrowing	-701,000
Free Cash Flow	-283.27M
FCF Per Share	-$3.43

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Replimune Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.99%
Shareholder Yield	-22.99%
Earnings Yield	-143.89%
FCF Yield	-129.45%

Analyst Forecast

The average price target for Replimune Group is $5.67, which is 120.62% higher than the current price. The consensus rating is "Hold".

Price Target	$5.67
Price Target Difference	120.62%
Analyst Consensus	Hold
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1